Novel xanthine oxidase-based cell model using HK-2 cell for screening antihyperuricemic functional compounds
- 10 April 2019
- journal article
- research article
- Published by Elsevier BV in Free Radical Biology & Medicine
- Vol. 136, 135-145
- https://doi.org/10.1016/j.freeradbiomed.2019.04.007
Abstract
No abstract availableFunding Information
- National Key R&D Program of China (2018YFD0901101)
- National Natural Science Foundation of China (31671804)
- Guangdong Science and Technology Planning Project (2017B090901063)
- Science and Technology Program of Guangzhou (201604020047)
This publication has 29 references indexed in Scilit:
- Metabolic syndrome: prevalence and risk factors in Korean gout patientsThe Korean Journal of Internal Medicine, 2018
- Antigout Effects of Plantago asiatica: Xanthine Oxidase Inhibitory Activities Assessed by Electrochemical Biosensing MethodEvidence-Based Complementary and Alternative Medicine, 2018
- Prevalence of Hyperuricemia and Gout in Mainland China from 2000 to 2014: A Systematic Review and Meta-AnalysisBioMed Research International, 2015
- Development of a Dual‐Energy Computed Tomography Scoring System for Measurement of Urate Deposition in GoutArthritis Care & Research, 2015
- Hyperuricemia-induced inflammasome and kidney diseasesNephrology Dialysis Transplantation, 2015
- High-performance liquid chromatography coupled with post-column dual-bioactivity assay for simultaneous screening of xanthine oxidase inhibitors and free radical scavengers from complex mixtureJournal of Chromatography A, 2014
- Optimizing current treatment of goutNature Reviews Rheumatology, 2014
- Uric Acid Oxidation as a Biomarker of Cardiovascular DiseaseFree Radical Biology & Medicine, 2013
- Prevalence of gout and hyperuricemia in the US general population: The National Health and Nutrition Examination Survey 2007-2008Arthritis & Rheumatism, 2011
- Uric acid transport and diseaseJCI Insight, 2010